After decades of research, there is still no cure for the disease HIV causes–AIDS. Each year, HIV infects more than one million people worldwide, and a vaccine remains stubbornly out of reach. Hope, ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A supercharged HIV vaccine could offer strong protection with just one ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional ...

Scientists have been developing mRNA vaccines against HIV, with one approach recently showing strong early results in animal and human studies. | Credit: Catherine Falls Commercial via Getty Images ...

Human immunodeficiency virus-1 (HIV-1) remains a global health crisis, with over 40 million people living with the virus and no effective vaccine available. Central to HIV infection and immune evasion ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies ...

Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...

There is still no cure or effective vaccine for HIV-1, which remains a public health threat. But scientists have opened up new possibilities in HIV treatment and vaccine development. A Step Towards a ...

Add Yahoo as a preferred source to see more of our stories on Google. STORY: This South African lab may be close to a breakthrough in the fight against HIV - but its researchers have had to stop work, ...

A recombinant zoster vaccine builds strong antibody protection in people living with HIV, regardless of their CD4 count — but their cellular immune response still lags behind those without HIV.

In January 2025, Linda-Gail Bekker stood inside a vaccine manufacturing plant and allowed herself to believe that the first HIV vaccine candidate conceived through African science and led by Africans ...

Louis Shackelford, MPH, is the Director of External Relations at the HIV Vaccine Trials Network (HVTN), where he leads public communications, community partnerships, and engagement efforts supporting ...